par Zhang, Steven;Zannikos, Peter;Awada, Ahmad
;Piccart-Gebhart, Martine
;Dirix, Luc Y;Fumoleau, Pierre;Verhaeghe, Tom;Francois, Marc;De Porre, Peter
Référence Journal of clinical pharmacology, 46, 10, page (1116-1127)
Publication Publié, 2006-10


Référence Journal of clinical pharmacology, 46, 10, page (1116-1127)
Publication Publié, 2006-10
Article révisé par les pairs
Titre: |
|
Auteur: | Zhang, Steven; Zannikos, Peter; Awada, Ahmad; Piccart-Gebhart, Martine; Dirix, Luc Y; Fumoleau, Pierre; Verhaeghe, Tom; Francois, Marc; De Porre, Peter |
Informations sur la publication: | Journal of clinical pharmacology, 46, 10, page (1116-1127) |
Statut de publication: | Publié, 2006-10 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Intravenous infusion |
Metabolite | |
Oral administration | |
Pharmacokinetics | |
Protein binding | |
Tipifarnib | |
MeSH keywords: | Administration, Oral |
Adult | |
Aged | |
Area Under Curve | |
Biological Availability | |
Dose-Response Relationship, Drug | |
Drug Administration Schedule | |
Enzyme Inhibitors -- administration & dosage | |
Enzyme Inhibitors -- pharmacokinetics | |
Farnesyltranstransferase -- antagonists & inhibitors | |
Female | |
Glucuronides -- metabolism | |
Glycoproteins -- metabolism | |
Humans | |
Infusions, Intravenous | |
Male | |
Metabolic Clearance Rate | |
Middle Aged | |
Neoplasms -- drug therapy | |
Neoplasms -- metabolism | |
Protein Binding | |
Quinolones -- metabolism | |
Quinolones -- pharmacokinetics | |
Quinolones -- therapeutic use | |
Serum Albumin -- metabolism | |
Tablets | |
Treatment Outcome | |
Note générale: | Journal Article |
Randomized Controlled Trial | |
FLWIN | |
Langue: | Anglais |
Identificateurs: | urn:issn:0091-2700 |
info:doi/10.1177/0091270006291034 | |
info:pii/46/10/1116 | |
info:scp/33748643781 | |
info:pmid/16988200 |